R. Fonseca, S. Abouzaid, and M. Bonafede, Trends in overall survival and costs of multiple myeloma, 2000???2014, Leukemia, vol.122, issue.9, pp.1915-1921, 2000.
DOI : 10.1111/j.1365-2141.2012.09124.x

J. Laubach, L. Garderet, and A. Mahindra, Management of relapsed multiple myeloma: recommendations of the International Myeloma Working Group The role of imaging in the treatment of patients with multiple myeloma in 2016, Leukemia. Am Soc Clin Oncol Educ Book, vol.3035, pp.1005-1017, 2016.

P. Moreau, M. Attal, and D. Caillot, Prospective evaluation of magnetic resonance imaging and [(18)F]fluorodeoxyglucose positron emission tomography-computed tomography at diagnosis and before maintenance therapy in symptomatic patients with multiple myeloma included in the IFM/DFCI 2009 trial: results of the IMAJEM study, J Clin Oncol, vol.355, pp.2911-2918, 2017.

C. Lapa, K. L?-uckerath, and U. Malzahn, ¹⁸ FDG-PET/CT for prognostic stratification of patients with multiple myeloma relapse after stem cell transplantation, Oncotarget, vol.5, issue.17, pp.7381-7391, 2014.
DOI : 10.18632/oncotarget.2290

T. Derlin, C. Weber, and C. Habermann, 18F-FDG PET/CT for detection and localization of residual or recurrent disease in patients with multiple myeloma after stem cell transplantation, European Journal of Nuclear Medicine and Molecular Imaging, vol.114, issue.3, pp.493-500, 2012.
DOI : 10.1182/blood-2009-03-213280

B. Elliott, S. Peti, and K. Osman, Combining FDG-PET/CT with laboratory data yields superior results for prediction of relapse in multiple myeloma Role of 18F-FDG positron emission tomography/computed tomography in the diagnosis and management of multiple myeloma and other plasma cell dyscrasias: a consensus statement by the International Myeloma Working Group, Eur J Haematol. Lancet Oncol, vol.8618, pp.289-298, 2011.

T. Bartel, J. Haessler, and T. Brown, F18-fluorodeoxyglucose positron emission tomography in the context of other imaging techniques and prognostic factors in multiple myeloma, Blood, vol.114, issue.10, pp.2068-2076, 2009.
DOI : 10.1182/blood-2009-03-213280

E. Zamagni, F. Patriarca, and C. Nanni, Prognostic relevance of 18-F FDG PET/CT in newly diagnosed multiple myeloma patients treated with up-front autologous transplantation Whole-body MRI versus PET in assessment of multiple myeloma disease activity Prognostic implications of serial 18-fluoro-deoxyglucose emission tomography in multiple myeloma treated with total therapy 3, Blood. Am J Roentgenol. Blood, vol.1181921212113, pp.5989-5995980, 2009.

E. Zamagni, C. Nanni, and K. Mancuso, CT improves the definition of complete response and allows to detect otherwise unidentifiable skeletal progression in multiple myeloma The bone marrow microenvironment as a tumor sanctuary and contributor to drug resistance, Clin Cancer Res. Clin Cancer Res, vol.211414, pp.4384-43902519, 2008.